Q3 2015 13F Holders as of 9/30/2015
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
79.2M
-
Number of holders
-
150
-
Total 13F shares, excl. options
-
32.6M
-
Shares change
-
+71.1K
-
Total reported value, excl. options
-
$870M
-
Value change
-
-$27.5M
-
Put/Call ratio
-
0.76
-
Number of buys
-
94
-
Number of sells
-
-75
-
Price
-
$26.70
Significant Holders of PTC THERAPEUTICS, INC. - Common Stock, $0.001 par value per share (PTCT) as of Q3 2015
222 filings reported holding PTCT - PTC THERAPEUTICS, INC. - Common Stock, $0.001 par value per share as of Q3 2015.
PTC THERAPEUTICS, INC. - Common Stock, $0.001 par value per share (PTCT) has 150 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 32.6M shares
of 79.2M outstanding shares and own 41.14% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (1.99M shares), WELLINGTON MANAGEMENT GROUP LLP (1.97M shares), WELLS FARGO & COMPANY/MN (1.91M shares), WADDELL & REED FINANCIAL INC (1.79M shares), FMR LLC (1.45M shares), BlackRock Fund Advisors (1.3M shares), BB BIOTECH AG (1.3M shares), WESTFIELD CAPITAL MANAGEMENT CO LP (1.25M shares), STATE STREET CORP (1.16M shares), and ALLIANCEBERNSTEIN L.P. (1.03M shares).
This table shows the top 150 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.